期刊文献+

帕米膦酸二钠治疗转移性骨肿瘤疼痛的效果观察 被引量:4

Effect of Disodium Pamidronate in the treatment of metastatic bone tumor pain
下载PDF
导出
摘要 目的 观察帕米膦酸二钠对癌骨转移的止痛效果、活动能力变化及不良反应。方法 对 42例确诊骨转移癌患者静脉滴注帕米膦酸二钠 60mg,每 2周重复。 结果 止痛显效 1 2例 ,有效 2 4例 ,无效 6例 ,总有效率 85 .7% ,活动能力改善有效率 64 .2 % ,不良反应轻微。 Objective To evaluate the efficacy of Disodium Pamidronate on relieving pain due to metastatic bone tumor and the changes of movement ability and side effects. Methods 42 patients diagnosing with metastatic bone tumor were given Disodium Pamidronate 60mg by intravenous infusion. The treatment were repeated once every two weeks. Results Complete relief of pain was observed in 12 patients, partial relief in 24 patients. The treatment was of no effect in 6 patients. The total effective rate was 85.7%, the improved effective rate of moving ability was 64.2%. The side effect was slightly. Conclusions Disodium Pamidronate is a good pain reliever in treatment patients with metastatic cancer of the bone.
出处 《右江民族医学院学报》 2002年第2期190-191,共2页 Journal of Youjiang Medical University for Nationalities
关键词 二磷酸盐类 肿瘤转移 继发性骨肿瘤 疼痛 顽固性 骨质溶解 diphosphonates neoplasm metastasis bone neoplasms-secondary pain, intractable osteolysis
  • 相关文献

同被引文献16

  • 1何萍,张俊萍.唑来磷酸钠治疗肺癌骨转移的临床研究[J].中国现代药物应用,2007,1(1). 被引量:2
  • 2袭燕,梁婧,刘晓琳,李岩.唑来膦酸联合化疗对恶性肿瘤骨转移的疗效分析[J].国际肿瘤学杂志,2006,33(2):157-160. 被引量:9
  • 3李增云,马庆彤,任晓,刘娜,陈树泉,王达,王健.唑来膦酸联合放疗治疗骨转移性疼痛的临床观察[J].四川肿瘤防治,2006,19(3):208-209. 被引量:11
  • 4Thomas JP,Vladimir M.Zoledronic acid in the management of metastatic bone disease[J].Ther Clin Risk Manag,2008;4:261-8.
  • 5Coleman RE.Skeletal complications of malignancy[J].Cancer,1997;80:1588-94.
  • 6Saad F,Olsson C,Schulman CC.Skeletal morbidity in men with prostate cancer:quality-of-life considerations throughout the continous of care[J].Eur Urol,2004;46:731-9.
  • 7Costa L,Lipton A,Coleman RE.Role of bisphosphonates for the management of skeletal complications and bone pain from skeletal metastases[J].Support Cancer Ther,2006;3:143-53.
  • 8Kakonen SM,Mundy GR.Mechanisms of osteolytic bone metastases in breast carcinoma[J].Cancer,2003;97:834-9.
  • 9Fleisch H.Development of bisphosphonates[J].Breast Cancer Res,2002;4:30-4.
  • 10Green JR.Bisphosphonates:preclinical review[J].Oncologist,2004;9(Suppl 4):3-13.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部